The purpose of this chapter is to implement the provisions at P.L. 2023, c. 106 (N.J.S.A. 45:14-82.2 et seq.), which requires registration, notification, and reporting to the Division by reporting entities to make clear the major components of prescription drug pricing along the supply chain and the impacts on insurance premiums and consumer cost sharing.
N.J. Admin. Code § 13:45K-1.1